Maternal DHA supplementation protects rat offspring against impairment of learning and memory following prenatal exposure to valproic acid

J Nutr Biochem. 2016 Sep:35:87-95. doi: 10.1016/j.jnutbio.2016.07.003. Epub 2016 Jul 9.

Abstract

Docosahexaenoic acid (22:6n-3; DHA) is known to play a critical role in postnatal brain development. However, there have been no studies investigating the preventive effect of DHA on prenatal valproic acid (VPA)-induced behavioral and molecular alterations in offspring. The present study was to evaluate the neuroprotective effects in offspring using maternal feeding of DHA to rats exposed to VPA in pregnancy. In the present study, rats were exposed to VPA on day 12.5 of pregnancy; DHA was administered at the dosages of 100, 300 and 500 mg/kg/day for 3 weeks from day 1 to 21 of pregnancy. The results showed that maternal feeding of DHA to the prenatal exposed to VPA (1) prevented VPA-induced learning and memory impairment but did not change social-related behavior, (2) increased total DHA content in offspring plasma and hippocampus, (3) rescued VPA-induced neuronal loss and apoptosis of pyramidal cells in hippocampal CA1, (4) influenced the content of malondialdehyde and glutathione and the activities of superoxide dismutase and glutathione in the hippocampus, (5) altered levels of apoptosis-related proteins (Bcl-2, Bax and caspase-3) and inhibited the activity of caspase-3 in offspring hippocampus and (6) enhanced relative levels of p-CaMKII and p-CREB proteins in the hippocampus. These findings suggest that maternal feeding with DHA may prevent prenatal VPA-induced impairment of learning and memory, normalize several different molecules associated with oxidative stress and apoptosis in the hippocampus of offspring, and exert preventive effects on prenatal VPA-induced brain dysfunction.

Keywords: Docosahexaenoic acid (DHA); Learning; Maternal feeding; Memory; Valproic acid (VPA).

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Anticonvulsants / adverse effects*
  • Anticonvulsants / chemistry
  • Behavior, Animal / drug effects
  • CA1 Region, Hippocampal / drug effects
  • CA1 Region, Hippocampal / metabolism
  • CA1 Region, Hippocampal / pathology
  • Dietary Supplements
  • Docosahexaenoic Acids / administration & dosage
  • Docosahexaenoic Acids / metabolism
  • Docosahexaenoic Acids / therapeutic use*
  • Female
  • Learning Disabilities / chemically induced
  • Learning Disabilities / metabolism
  • Learning Disabilities / pathology
  • Learning Disabilities / prevention & control*
  • Male
  • Maternal Nutritional Physiological Phenomena*
  • Maze Learning / drug effects
  • Memory Disorders / chemically induced
  • Memory Disorders / metabolism
  • Memory Disorders / pathology
  • Memory Disorders / prevention & control*
  • Nerve Tissue Proteins / metabolism
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Neuroprotective Agents / therapeutic use
  • Phosphorylation / drug effects
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Protein Processing, Post-Translational / drug effects
  • Rats, Wistar
  • Social Behavior
  • Valproic Acid / adverse effects*
  • Valproic Acid / antagonists & inhibitors

Substances

  • Anticonvulsants
  • Nerve Tissue Proteins
  • Neuroprotective Agents
  • Docosahexaenoic Acids
  • Valproic Acid